American Century Companies’s AbCellera Biologics ABCL Stock Holding History
Bought
Maintained
Sold
Other funds holding ABCL
BBA
TWC
ACH
DCM
American Century Companies's ABCL Position: Q2 2026 in Review
American Century Companies held its AbCellera Biologics (ABCL) position steady in Q2 2026 at 109,011 shares worth $856K. The position accounts for ﹤0.01% of the portfolio, ranked #2445.
American Century Companies first reported a position in ABCL in Q3 2022 and has held it in 16 quarters since. The position peaked at $13.1M in Q4 2022. 150 funds tracked by Wall St. Rank hold ABCL as of Q2 2026.
- American Century Companies held 109,011 shares of AbCellera Biologics worth $856K as of Q2 2026.
- American Century Companies left its AbCellera Biologics share count unchanged in Q2 2026.
- AbCellera Biologics made up ﹤0.01% of American Century Companies's portfolio in Q2 2026, its #2445 holding.
- American Century Companies first reported a position in AbCellera Biologics in Q3 2022 and has held it in 16 quarters since.
- American Century Companies's AbCellera Biologics position peaked at $13.1M in Q4 2022.
- 150 funds tracked by Wall St. Rank held AbCellera Biologics as of Q2 2026.
Based on American Century Companies's 13F filing for Q2 2026, filed 12 Aug 2026.